PEMETREXED TEVA RTU 25 MGML

Երկիր: Իսրայել

Լեզու: անգլերեն

Աղբյուրը: Ministry of Health

Ակտիվ բաղադրիչ:

PEMETREXED

Հասանելի է:

ABIC MARKETING LTD, ISRAEL

ATC կոդը:

L01BA04

Դեղագործական ձեւ:

CONCENTRATE FOR SOLUTION FOR INFUSION

Կազմը:

PEMETREXED 25 MG / 1 ML

Կառավարման երթուղին:

I.V

Ռեկվիզորի տեսակը:

Required

Պատրաստված է:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Թերապեւտիկ տարածք:

PEMETREXED

Թերապեւտիկ ցուցումներ:

Pemetrexed Teva RTU in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Pemetrexed Teva RTU in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva RTU is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva RTU is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

Հաստատման ամսաթիվը:

2018-01-03